SingaporeTaevas Global guides food and dietary supplement manufacturers through Singapore's HSA regulatory framework, ensuring compliant product registration and a faster, lower-risk path to one of Southeast Asia's most lucrative health consumer markets.
Our six interconnected pillars give food and dietary supplement companies a complete picture of Singapore's regulatory landscape, market dynamics, and competitive environment so every registration decision is grounded in verified local intelligence.
We decode Singapore's dual-authority framework under HSA and SFA, clarifying which products fall under the Health Products Act as health supplements versus conventional foods under the Sale of Food Act. Our team translates complex legislative requirements into actionable compliance roadmaps tailored to your product category.
Our four-stage engagement moves from initial product scoping through deep regulatory research and dossier preparation to a final debrief that equips your leadership team to act immediately.
We begin with a structured intake session to understand your product formulation, intended claims, target consumer segment, and commercial timeline. This session captures the information needed to determine the correct regulatory pathway under HSA or SFA and to scope the full engagement accurately.
During intake, our regulatory specialists review your existing technical documentation, ingredient specifications, and any prior regulatory history in other markets. We identify immediate red flags such as prohibited ingredients or unapproved claims and provide a preliminary classification opinion within 48 hours of the session, giving your team early certainty before the full engagement begins.
Singapore's population ranks among Southeast Asia's most health-aware, with high disposable incomes and strong demand for premium vitamins, probiotics, and functional food products. The city-state's ageing demographic profile is accelerating growth in bone health, cognitive support, and cardiovascular supplement categories, creating sustained demand for well-positioned imported brands.
Singapore operates a bifurcated regulatory system where HSA governs health supplements under the Health Products Act and SFA governs conventional and novel foods under the Sale of Food Act. Misclassification between the two authorities is one of the most common and costly errors for foreign manufacturers, making expert pre-submission classification analysis essential before any dossier investment.
Singapore's transparent regulatory environment and international reputation make it the preferred first-entry market for food and supplement brands targeting broader Southeast Asian expansion. A successful HSA or SFA registration provides credibility and reference documentation that materially accelerates subsequent filings in Malaysia, Indonesia, Thailand, and the Philippines under ASEAN harmonisation frameworks.
Online supplement sales in Singapore have grown significantly, driven by platforms such as Lazada, Shopee, and direct-to-consumer brand websites. However, online advertising of health supplements is subject to the same HSA claims restrictions as physical retail, and non-compliant digital marketing remains a leading cause of post-market enforcement actions against foreign brands.
Every Taevas Global Product Registration engagement for Singapore delivers eight structured outputs that give your regulatory, commercial, and legal teams the precise intelligence needed to file with confidence and launch without delay.
A written determination of whether your product registers under HSA as a health supplement or under SFA as a food or novel food, with the legal basis and implications for claims, labelling, and post-market obligations clearly documented.
A line-by-line assessment of every active and inactive ingredient against Singapore's permitted lists, contaminant limits, and additive schedules, with specific remediation recommendations for any non-compliant components.
A detailed mark-up of your proposed label against Singapore Food Regulations and HSA health supplement labelling requirements, accompanied by a compliant artwork brief ready for your design team to implement.
A structured comparison of your intended product claims against HSA's approved health claims list and SFA's nutrition content claim guidelines, with compliant alternative wording for any claims that cannot be substantiated under Singapore law.
A practical guide covering import permit requirements, applicable HS codes, recommended Singapore-accredited testing laboratories, and key distributor and retail pharmacy channel considerations for your product category.
An analysis of comparable products already registered or notified in Singapore, including positioning, claims used, and pricing benchmarks, giving your commercial team the context needed to differentiate effectively at launch.
A complete, quality-checked registration dossier prepared to HSA PRISM or SFA GoBusiness submission standards, including product specifications, safety summary, labelling files, and all supporting documentation.
A concise reference document outlining Singapore's post-market surveillance requirements, adverse event reporting obligations, variation management triggers, and renewal timelines so your team stays compliant after approval.
Your company has a proven supplement or functional food product in your home market and has identified Singapore as the priority entry point into Southeast Asia. You need a clear, accurate understanding of whether your product qualifies as a health supplement under HSA or a food under SFA, what documentation is required, and how long the process will realistically take before you commit budget and inventory.
Whether you are filing your first health supplement notification with HSA or remediating an existing compliance issue, Taevas Global gives you the regulatory expertise and market intelligence to move faster and with greater certainty in Singapore.